astrazeneca plc
(AZN:London Stock Exchange)
Executive Profile*
Simon Jonathan LowthChief Financial Officer, Executive Director and Chairman of Disclosure Committee, AstraZeneca PLC |
| Age | Total Calculated Compensation | This person is connected to 51 board members in 3 different organizations across 4 different industries. See Board Relationships |
| 50 | 2,080,000 GBP As of Fiscal Year 2012 |
Background*
Mr. Simon Jonathan Lowth serves as the Chief Financial Officer of AstraZeneca PLC since November 5, 2007. Mr. Lowth serves as Finance Director of ScottishPower (DLC) Ltd. since May 2006 and has been its Executive Director of Corporate Strategy and Development since September 1, 2003. He served as an Interim Chief Executive Officer at AstraZeneca PLC since June 1, 2012. He served as the Director of Finance and Strategy of Scottish Power PLC from May 24, 2005 to 2007. ...
Corporate Headquarters*2 Kingdom StreetLondon, Greater London W2 6BD United Kingdom Phone: 44 20 7604 8000 Fax: 44 20 7604 8151 Board Members Memberships*2003-2007 Former Director of Finance & Strategy and Member of Group Finance Committee 2003-Present Finance Director, Executive Director of Corporate Strategy & Development and Executive Director 2007-Present Chief Financial Officer, Executive Director and Chairman of Disclosure Committee 2010-Present Independent Non-Executive Director and Member of Board Risk Committee
Education*MA University of Cambridge BE University of Cambridge MBA London Business School
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| AZN:LN | 3,428.00 GBp | +1.50 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Lamberto Andreotti | Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee Bristol-Myers Squibb Company | $1.6M |
| George A. Scangos Ph.D. | Chief Executive Officer and Director Biogen Idec Inc. | $1.3M |
| Miles D. White | Chairman, Chief Executive Officer and Chairman of Executive Committee Abbott Laboratories | $1.9M |
| Lars Rebien Sørensen | Chief Executive Officer, President and Member of the Senior Management Board Novo Nordisk A/S | kr11.3M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
